Ipamorelin (NNC 26-0161)
711.9 Da
Liquid
~2 hours
Refrigerate at 2–8°C, protect from light
// PAI-2026-05
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It is one of the cleanest GH-releasing peptides studied, with high selectivity for GH release without significant increases in cortisol, prolactin, or ACTH. Research focuses on its potential for improving body composition, recovery, sleep quality, and metabolic function.
Select Quantity
10 mg · Lyophilized
$134.06
per mg
$13.41
Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Liquid formulation — ready to use
Batch PAI-2026-05 · Issued Jul 26, 2026
99.6%
RP-HPLC · UV 220nm
Confirmed
LC-MS/MS · ESI+
<0.1 EU/mg
LAL method
<10 CFU/g
USP <61>
HPLC Purity Profile
99.6% main peak| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Purity (HPLC) | RP-HPLC | ≥98.0% | 99.6% | PASS |
| Identity (MS) | LC-MS/MS | Conforms | Conforms | PASS |
| Appearance | Visual | White powder | Conforms | PASS |
| Moisture | Karl Fischer | ≤8.0% | 3.6% | PASS |
| Residual Solvents | GC-HS | ICH Q3C | Conforms | PASS |
| Endotoxins | LAL | <1 EU/mg | <0.1 EU/mg | PASS |
Testing performed by independent ISO-accredited laboratory. Full chromatograms and spectra available in the downloadable COA document.
Ipamorelin: a new growth hormone-releasing peptide
Eur J Endocrinol · 1998
Selectivity of Ipamorelin vs other GH secretagogues
Growth Horm IGF Res · 1999
For research purposes only. These references are provided for informational use and do not constitute medical advice.
≥99.5% purity · 3367.9 Da
Long-acting GHRH analogue that stimulates sustained growth hormone release. Studied for body composition, recovery, and anti-aging.
≥99.5% purity · —
Synergistic GHRH + GHS combination for amplified, pulsatile growth hormone release. The gold standard GH peptide stack.
≥99.5% purity · 7649.1 Da
Potent anabolic growth factor mediating many effects of GH. Studied for muscle growth, recovery, neuroprotection, and metabolic health.